Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a multicentric, open-label,non-randomized concurrent control, 1:1
match,non-inferiority trial that assesses the efficacy and safety of neoadjuvant chemotherapy
regimen DC-T and EC-T in breast cancer patients.
Phase:
Phase 4
Details
Lead Sponsor:
Zhejiang University
Collaborators:
First Affiliated Hospital of Wenzhou Medical University First Affiliated Hospital of Zhejiang University First People's Hospital of Hangzhou Hangzhou Hospital of Traditional Chinese Medicine Jinhua Central Hospital Ningbo No. 1 Hospital Second Affiliated Hospital, School of Medicine, Zhejiang University Sir Run Run Shaw Hospital Women's Hospital School Of Medicine Zhejiang University Zhejiang Cancer Hospital Zhejiang Provincial Hospital of TCM Zhejiang Provincial People's Hospital Zhejiang Provincial People’s Hospital